Navigation Links
Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
Date:9/5/2007

mplex than the patients treated with the bare metal stent.

"The results from ARTS II are excellent for the CYPHER(R) Stent in very complex patients. The ARTS I and II Studies were designed to provide valuable information to help physicians evaluate how to best improve clinical outcomes and increase the quality-of-life of patients with multivessel disease," said David E. Kandzari, M.D., F.A.C.C., F.S.C.A.I., Chief Medical Officer, Cordis Corporation. "Their results add to the large body of existing evidence assessing the performance of the CYPHER(R) Stent in a wide range of patient populations."

In the United States, the CYPHER(R) Stent is indicated for de novo lesions less than 30 mm in length in native coronary arteries between 2.5 mm and 3.5 mm in diameter. It does not have an approved indication for patients with multivessel disease, diabetes or blockages located at a bifurcation.

The ARTS II Study is sponsored by Cordis Corporation.

About the CYPHER(R) Stent

The CYPHER(R) Stent has been chosen by cardiologists worldwide to treat approximately three million patients with coronary artery disease. The safety and efficacy of the device is supported by a robust clinical trial program that includes more than 70 studies that examine the performance of the CYPHER(R) Stent in a broad range of patients.

Developed and manufactured by Cordis Corporation, the CYPHER(R) Stent is currently available in more than 80 countries and has the broadest clinical experience and longest-term clinical follow-up of any drug-eluting stent. The next version of sirolimus-eluting stent, the CYPHER SELECT(TM) Sirolimus- eluting Coronary Stent, was launched in Europe, Asia Pacific, Latin America and Canada in 2003. The CYPHER SELECT(TM) Plus Stent, the third version of a sirolimus-eluting coronary stent, received CE Mark in 2006 and is currently available in many markets outside the United States.

For more complete information on indications, contraindi
'/>"/>

SOURCE Cordis Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
2. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
3. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Data Analyses Outline Efficacy and Safety of Mircera for the Treatment of Renal Anemia Associated With Chronic Kidney Disease
5. Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
6. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
7. Genetic Analysis Systems Enter the Clinical Mainstream
8. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
9. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
10. Sygnis Pharma AG announces date for presentation of clinical results
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... Industry in the U.S. and its ... ,, http://www.reportlinker.com/p0167745/Surgical-and-Medical-Instrument-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, The ... and Medical Instrument Manufacturing Industry report ...
(Date:12/15/2009)... MILFORD, Mass., Dec. 15 ... ) today announced that SDMS Vision Publisher(TM) (v.7.1 ... NuGenesis® Scientific Data Management System (SDMS), a secure ... of scientific data to a centralized database and ... laboratories, has been certified compliant with the SAFE-BioPharma ...
(Date:12/15/2009)... -- NxStage Medical, Inc. (Nasdaq: NXTM ), ... announced that a group of its home hemodialysis ... a week-long, conventional (non-dialysis) Caribbean cruise with their ... the "2010 Freedom Cruise: We,re Taking Home Dialysis ... 3, 2010 and returns on January 10, 2010. ...
Breaking Medicine Technology:Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4Boost for Prostate Cancer Screening Report Shows Mortality Reduction as High as 31 25 15093 1Boost for Prostate Cancer Screening Report Shows Mortality Reduction as High as 31 25 15093 2Lyric Presents the Sounds of the Season 15092 1Lyric Presents the Sounds of the Season 15092 2Study Finds Family Members Play Critical Role in Addressing Loved Ones 26apos 3B Hearing Loss 62810 1Study Finds Family Members Play Critical Role in Addressing Loved Ones 26apos 3B Hearing Loss 62810 2Study Finds Family Members Play Critical Role in Addressing Loved Ones 26apos 3B Hearing Loss 62810 3Study Finds Family Members Play Critical Role in Addressing Loved Ones 26apos 3B Hearing Loss 62810 4
... Synbiotics Corporation today,announced that it is seeking 510(k) ... the use of its FluDetect(R) Avian Influenza Virus,rapid ... foray into the,human point-of-care diagnostic marketplace. While it ... itself to the human field, it is,actively seeking ...
... - In Children,s DNA, a Hint of a Mutation,s ... Genomics researchers,seeking to replicate another group,s discovery of an ... to a particular,variant in DNA that may be more ... human populations worldwide. The finding suggests that,the gene variant, ...
Other Medicine Technology:Synbiotics Corporation Announces Human Submission for FluDetect(R) 2Gene Hunters Fine-Tune Marker for Common Obesity Gene 2Gene Hunters Fine-Tune Marker for Common Obesity Gene 3
(Date:12/15/2009)... lower strength than needed for protection, CDC says, , , ... doses of H1N1 swine flu vaccine have been recalled ... some potency, federal health officials said Tuesday. , According ... the company,s routine testing of the vaccine for children ... four batches had lower than required potency levels. "This ...
(Date:12/15/2009)... 4R Systems, Inc., a leading provider ... help retailers significantly increase profits by optimizing their ... that The Vitamin Shoppe has been utilizing the ... and DC inventory solutions have helped us drive ... over the last two years," said Tony Truesdale, ...
(Date:12/15/2009)... Dec. 15 North American application activity ... November year-over-year, according to the MIB Life ... applications over the past three months have lifted ... of -1.6%, to flat at November,s close, -0.1%. ... interest in the benefits available from life insurance," ...
(Date:12/15/2009)... United Nations Foundation has led the fight against malaria, ... Report 2009 that the global strategies for ending malaria deaths are ... the United Nations Foundation , ... Washington, D.C. (Vocus) ... Nations Foundation has led the fight against malaria, and I ...
(Date:12/15/2009)... secure USB devices, today launches SafeConsole 4.0, the web management ... is designed to provide better usability for employees and more ... range of licensing options. , ... ... ) a leading provider of secure USB devices, today launches ...
Breaking Medicine News(10 mins):Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 2Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 3
... Feb. 21 Writing of the Northern,Illinois University ... Carey, 2/19/08, A20) remarks " ... doctors say ... of violence stem in part from the,drug reactions ... Prozac to battle anxiety and compulsive behavior. While ...
... to Expanded Headquarters, BROOKFIELD, Wis., Feb. 21 ... human resources outsourcing company, secured new,contracts with leading ... Fortune 500 companies for Pinstripe,s RPO services. These ... 80 employees, with,a 300-percent growth in revenue., ...
... EDITOR,S PICK: Deficiency in the protein MBL2 is linked ... fibrosis (CF), a hereditary disorder causing thick mucous production ... mortality rate primarily due to lung failure. Although it ... the disease, variations in other genes between individuals with ...
... A new electron microscope recently installed in Cornell,s Duffield ... form images that uniquely identify individual atoms in a ... another. And in living color. , "The current generation ... black and white cameras where different atoms appear as ...
... kidneys from older donors is followed by increased stiffening ... higher rates of cardiovascular disease and death in patients ... in the April Journal of the American Society of ... Chaignon of Foch Hospital in Suresnes, France, and Jean-Philippe ...
... from a ruptured brain aneurysm has found that expensive ... platinum coils at preventing aneurysms from recurring. ... at the University of Cincinnati (UC) and University Hospital, ... intracranial aneurysm recurrence after endovascular treatment with each of ...
Other Medicine News:Health News:'The Northern Illinois University Murders Due to 'Chemical Imbalances' or 'Chemical Balancers' - Drugs?' - Fred A. Baughman Jr., MD, Neurologist/Child Neurologist 2Health News:'The Northern Illinois University Murders Due to 'Chemical Imbalances' or 'Chemical Balancers' - Drugs?' - Fred A. Baughman Jr., MD, Neurologist/Child Neurologist 3Health News:Significant Growth for Pinstripe Leads to Need for Larger Facility 2Health News:JCI table of contents: Feb. 21, 2008 2Health News:JCI table of contents: Feb. 21, 2008 3Health News:JCI table of contents: Feb. 21, 2008 4Health News:JCI table of contents: Feb. 21, 2008 5Health News:JCI table of contents: Feb. 21, 2008 6Health News:JCI table of contents: Feb. 21, 2008 7Health News:JCI table of contents: Feb. 21, 2008 8Health News:JCI table of contents: Feb. 21, 2008 9Health News:JCI table of contents: Feb. 21, 2008 10Health News:By color-coding atoms, new Cornell electron microscope promises big advance in materials analysis 2Health News:By color-coding atoms, new Cornell electron microscope promises big advance in materials analysis 3Health News:Kidney donor age linked to aortic siffening 2Health News:UC study: New devices less effective in thwarting brain aneurysm recurrence 2
... The Bio-Anchor implant is molded from Poly ... absorption rate to insure secure fixation throughout ... eliminates implant removal complications because it is ... be over-drilled. The ribbed, press-fit anchor ...
... RC implant is molded from Poly-L-Lactide Acid ... fixation, which include radiolucency and a history ... ,The simple screw-in method of insertion reduces ... repairing the rotator cuff. The anchor ...
... better. How can one of the leading ... becoming more convenient to use in all ... TwinFix Suture Anchor with Needles combines the ... and timesaving anchor inserter and needle delivery ...
The unique design of the TWINFIX Suture Anchors combines high resistance to pullout from our patented thread design with optimal knot tying from the DURABRAID suture....
Medicine Products: